| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Wolf-Dieter Heiss | |
| P2860 | cites work | A Positron-Emission Transaxial Tomograph for Nuclear Imaging (PETT) | Q28207715 |
| Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model | Q28344741 | ||
| The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders | Q30888331 | ||
| Proton MRI of metabolically produced H2 17O using an efficient 17O2 delivery system. | Q30938366 | ||
| Modeling the hemodynamic response to brain activation | Q30971791 | ||
| Imaging structure and function in refractory focal epilepsy | Q30979349 | ||
| Imaging in neurooncology | Q30989939 | ||
| New developments of brain imaging for Parkinson's disease and related disorders. | Q31050288 | ||
| Clinical applications of PET in brain tumors | Q31121989 | ||
| Molecular and cellular MR imaging: potentials and challenges for neurological applications | Q31147754 | ||
| A fusion PET-MRI system with a high-resolution research tomograph-PET and ultra-high field 7.0 T-MRI for the molecular-genetic imaging of the brain | Q31149502 | ||
| Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs | Q33696408 | ||
| A combined PET/CT scanner for clinical oncology. | Q33914145 | ||
| Ischemic penumbra: evidence from functional imaging in man. | Q34037705 | ||
| Kinetic modeling in positron emission tomography. | Q34694237 | ||
| Simultaneous PET-MRI: a new approach for functional and morphological imaging | Q34765886 | ||
| PET studies in dementia | Q35147026 | ||
| Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects | Q35591436 | ||
| Reproducibility of BOLD, perfusion, and CMRO2 measurements with calibrated-BOLD fMRI. | Q36086666 | ||
| Simultaneous in vivo positron emission tomography and magnetic resonance imaging. | Q36499125 | ||
| Cell transplantation therapy for stroke | Q36721703 | ||
| Advances in anatomic, functional, and molecular imaging of angiogenesis | Q37122921 | ||
| Factors affecting the clinical outcome after neural transplantation in Parkinson's disease | Q39360071 | ||
| Relation between 1H MR spectroscopic imaging and regional cerebral glucose metabolism in Alzheimer's disease. | Q43592164 | ||
| Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas | Q43733716 | ||
| ECAT: a new computerized tomographic imaging system for positron-emitting radiopharmaceuticals | Q44012198 | ||
| Identifying thresholds for penumbra and irreversible tissue damage | Q45086667 | ||
| Simultaneous MR/PET imaging of the human brain: feasibility study | Q46423745 | ||
| Performance evaluation of the positron scanner ECAT EXACT | Q46906466 | ||
| From the left to the right: How the brain compensates progressive loss of language function | Q46977617 | ||
| Imaging of acetylcholine esterase activity in brainstem nuclei involved in regulation of sleep and wakefulness | Q48150883 | ||
| Functional activation using apparent diffusion coefficient-dependent contrast allows better spatial localization to the neuronal activity: evidence using diffusion tensor imaging and fiber tracking | Q48167532 | ||
| The ECAT EXACT HR: performance of a new high resolution positron scanner. | Q48196843 | ||
| Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner | Q48272311 | ||
| Direct demonstration of transcallosal disinhibition in language networks | Q48507875 | ||
| In vivo imaging of glucose consumption and lactate concentration in human gliomas | Q48511503 | ||
| Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose | Q48661699 | ||
| Demonstration of decreased functional activity of visual cortex by [11 C]methylglucose and positron emission tomography | Q49076668 | ||
| Clinical applications of registration and fusion of multimodality brain images from PET, SPECT, CT, and MRI. | Q49134927 | ||
| Human 5-HT transporter availability predicts amygdala reactivity in vivo. | Q50890537 | ||
| Fast and robust registration of PET and MR images of human brain. | Q53624708 | ||
| Positron emission tomography and magnetic resonance spectroscopy of cerebral glycolysis in children with congenital lactic acidosis | Q63988553 | ||
| Metabolic changes in acute and subacute cerebral infarctions: findings at proton MR spectroscopic imaging | Q72321348 | ||
| P304 | page(s) | S105-12 | |
| P577 | publication date | 2009-03-01 | |
| P1433 | published in | European Journal of Nuclear Medicine and Molecular Imaging | Q15708890 |
| P1476 | title | The potential of PET/MR for brain imaging | |
| P478 | volume | 36 Suppl 1 |
| Q39092307 | A multi-centre evaluation of eleven clinically feasible brain PET/MRI attenuation correction techniques using a large cohort of patients. |
| Q58605518 | Accurate hybrid template-based and MR-based attenuation correction using UTE images for simultaneous PET/MR brain imaging applications |
| Q37947718 | Advances in imaging in Parkinson's disease. |
| Q48397717 | Attenuation correction for PET/MR: problems, novel approaches and practical solutions |
| Q28660586 | Auditory neuroimaging with fMRI and PET. |
| Q33628451 | Central nervous system lymphoma: characteristic findings on traditional and advanced imaging |
| Q26998774 | Clinical and research applications of simultaneous positron emission tomography and MRI |
| Q42566769 | Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17-21, 2014, Tübingen, Germany |
| Q38199374 | Combined PET/MR: Where are we now? Summary report of the second international workshop on PET/MR imaging April 8-12, 2013, Tubingen, Germany |
| Q47608030 | Combined PET/MRI: Global Warming-Summary Report of the 6th International Workshop on PET/MRI, March 27-29, 2017, Tübingen, Germany. |
| Q36769819 | Comparison of standardized uptake values in normal structures between PET/CT and PET/MRI in an oncology patient population |
| Q37238715 | Competitive advantage of PET/MRI. |
| Q39351705 | Conversion of arterial input functions for dual pharmacokinetic modeling using Gd-DTPA/MRI and 18F-FDG/PET. |
| Q30585141 | Does PET/MR in human brain imaging provide optimal co-registration? A critical reflection. |
| Q35155155 | Effects of magnetic fields of up to 9.4 T on resolution and contrast of PET images as measured with an MR-BrainPET. |
| Q27023823 | Emerging methods for disease monitoring in malignant gliomas |
| Q40475342 | Evaluation of in vivo quantification accuracy of the Ingenuity-TF PET/MR. |
| Q45299604 | Evaluation of whole-body MR to CT deformable image registration. |
| Q30940110 | Generation of a Four-Class Attenuation Map for MRI-Based Attenuation Correction of PET Data in the Head Area Using a Novel Combination of STE/Dixon-MRI and FCM Clustering |
| Q58109703 | Hybrid PET/MR: Updated Clinical Use and Potential Applications |
| Q34506838 | Image guided biodistribution and pharmacokinetic studies of theranostics |
| Q42235617 | Impact of MR-Based Attenuation Correction on Neurologic PET Studies. |
| Q34975185 | Integrated whole body MR/PET: where are we? |
| Q42160028 | Lhermitte-Duclos disease presenting with positron emission tomography-magnetic resonance fusion imaging: a case report |
| Q34493670 | MR-based PET motion correction procedure for simultaneous MR-PET neuroimaging of human brain. |
| Q30911035 | MR-based attenuation correction for PET/MRI neurological studies with continuous-valued attenuation coefficients for bone through a conversion from R2* to CT-Hounsfield units |
| Q90322266 | MRI-based attenuation correction for brain PET/MRI based on anatomic signature and machine learning |
| Q49029579 | MRI-guided attenuation correction in whole-body PET/MR: assessment of the effect of bone attenuation |
| Q42915631 | Multiscale segmentation of the skull in MR images for MRI-based attenuation correction of combined MR/PET. |
| Q38241315 | PET imaging in ischemic cerebrovascular disease: current status and future directions |
| Q42430515 | PET-MRI: Challenges and new directions |
| Q38085153 | PET/MR: a paradigm shift |
| Q48158155 | Positron emission tomography imaging in gliomas: applications in clinical diagnosis, for assessment of prognosis and of treatment effects, and for detection of recurrences |
| Q33991881 | Positron emission tomography molecular imaging for drug development |
| Q36609754 | Quantitative accuracy of attenuation correction in the Philips Ingenuity TF whole-body PET/MR system: a direct comparison with transmission-based attenuation correction |
| Q36158324 | Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals |
| Q30420115 | Sequential whole-body PET/MR scanner: concept, clinical use, and optimisation after two years in the clinic. The manufacturer's perspective |
| Q43476008 | Technical performance evaluation of a human brain PET/MRI system |
| Q35723808 | The future of hybrid imaging-part 3: PET/MR, small-animal imaging and beyond. |
Search more.